Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CXCR4 | P61073 | 2/20 | 0.61 |
| ▸ | EPHA2 | P29317 | 2/20 | 0.60 |
| ▸ | NMUR2 | Q9GZQ4 | 3/20 | 0.58 |
| ▸ | NMUR1 | Q9HB89 | 3/20 | 0.58 |
| ▸ | TFPI | P10646 | 4/20 | 0.58 |
| ▸ | NPY2R | P49146 | 6/20 | 0.58 |
| ▸ | NPY4R | P50391 | 6/20 | 0.58 |
| ▸ | NPY5R | Q15761 | 6/20 | 0.58 |
| ▸ | NPY1R | P25929 | 4/20 | 0.58 |
| ▸ | RAMP3 | O60896 | 1/20 | 0.57 |
| ▸ | CALCR | P30988 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30415150 | 0.96 | EPHA2 (0.62) | CXCR4EPHA2NMUR2NMUR1TFPI | |
| Rusalatide SCHEMBL29392126 | 0.95 | EPHA2 (0.62) | CXCR4EPHA2TFPINPY2RNPY4R | |
| Rusalatide SCHEMBL29357268 | 0.95 | TFPI (0.62) | CXCR4EPHA2TFPINPY2RNPY4R | |
| SCHEMBL30415361 | 0.94 | EPHA2 (0.65) | CXCR4EPHA2NMUR2NMUR1TFPI | |
| SCHEMBL29390108 | 0.93 | EPHA2 (0.62) | CXCR4EPHA2TFPINPY2RNPY4R | |
| SCHEMBL30415710 | 0.93 | EPHA2 (0.65) | EPHA2TFPINPY2RNPY4RNPY5R | |
| SCHEMBL30415381 | 0.93 | EPHA2 (0.65) | EPHA2TFPINPY2RNPY4RNPY5R | |
| SCHEMBL30186436 | 0.93 | CXCR4 (0.58) | CXCR4EPHA2NMUR2NMUR1TFPI | |
| SCHEMBL30186412 | 0.91 | EPHA2 (0.65) | EPHA2NMUR2NMUR1TFPINPY2R | |
| SCHEMBL29392765 | 0.90 | EPHA2 (0.57) | CXCR4EPHA2TFPINPY2RNPY4R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250186339-A1 | COMPOSITION FOR INTRAORAL DELIVERY OF BIOLOGICALLY ACTIVE PEPTIDES AND PROTEINS | SCHWARZ JOSEPH (CA) | 2025-06-12 | — | — | US | disclosed |
| US-12246087-B2 | Composition for intraoral delivery of biologically active peptides and proteins | PHARCON INC (CA) | 2025-03-11 | — | — | US | disclosed |